[Federal Register: April 12, 2001 (Volume 66, Number 71)]
[Notices]
[Page 18937-18938]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr12ap01-58]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Notice of Meeting: Secretary's Advisory Committee on Genetic
Testing
Pursuant to Public Law 92-463, notice is hereby given of the ninth
meeting of the Secretary's Advisory Committee on Genetic Testing
(SACGT), U.S. Public Health Service. The meeting will be held from 9:00
a.m. to 5:00 p.m. on May 2, 2001 and 8:30 a.m. to 3:00 p.m. on May 3,
2001 at the National Institutes of Health, Building 31, C Wing,
Conference Room 10, 9000 Rockville Pike, Bethesda, MD 20892. The
meeting will be open to the public with attendance limited to space
available.
The Committee will discuss a number of topics, including continuing
FDA activities to develop a review template for genetic tests and FDA's
labeling authorities as they pertain to genetic tests, as well as
interagency progress on the development of coordinated genetic testing
information systems. The Committee will begin exploring best practices
in the development of clinical guidelines for genetic testing and hear
progress reports from the Committee's work groups. There will be time
provided for public comment and interested individuals should notify
the contact person listed below. The Committee is particularly
interested in hearing from members of the public about FDA's draft
review template for genetic tests. Copies of the draft template can be
obtained from SACGT staff listed below.
Under authority of 42 U.S.C. 217(a), Section 222 of the Public
Health Service Act, as amended, the Department of Health and Human
Services established SACGT to advise and make recommendations to the
Secretary through the Assistant Secretary for Health on all aspects of
the development and use of genetic tests.
[[Page 18938]]
The SACGT is directed to (1) recommend policies and procedures for the
safe and effective incorporation of genetic technologies into health
care; (2) assess the effectiveness of existing and future measures for
oversight of genetic tests; and (3) identify research needs related to
the Committee's purview.
The draft meeting agenda and other information about SACGT will be
available at the following web site: http://www4.od.nih.gov/oba/
sacgt.htm. Individuals who wish to provide public comments or who plan
to attend the meeting and need special assistance, such as sign
language interpretation or other reasonable accommodations, should
notify the SACGT Executive Secretary, Ms. Sarah Carr, by telephone at
301-496-9838 or E-mail at sc112c@nih.gov. The SACGT office is located
at 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892.
Dated: April 4, 2001.
Sarah Carr,
Executive Secretary, SACGT.
[FR Doc. 01-9012 Filed 4-11-01; 8:45 am]
BILLING CODE 4140-01-M